The heterotopically transplanted rat heart provides a unique model for examination of the direct humoral effects on the myocardium since the transplanted heart is exposed to the same hormonal milieu as the in situ heart but does not support the hemodynamic load. In this model, the heart of an inbred rat is transplanted into the abdomen of a recipient of the same inbred strain by attaching the stumps of aorta and pulmonary artery end to side to the abdominal aorta and inferior vena cava of the recipient. The transplanted heart is perfused by the recipients' blood through the coronary vessels. Its left ventricle beats mostly isovolumically and at a slower rate than the heart in situ. The transplant functions as a denervated "non working" Langendorf heart and does not appreciably contribute to the haemodynamics, while the recipient in situ heart supports the haemodynamics and serves as a control heart. The above model has been used to study the direct and indirect effects of thyroxine, catecholamines and of physical exercise on the cardiac mass and on its structure, function and chemical composition. It can also be used to study the acute and chronic effects of unloading and subsequent reloading. It can also shed some light upon the effect of denervation and potential reinnervation of the myocardium.
INTRODUCTION
After the microvascular suture, techniques were developed in small laboratory animals in the sixties almost all organ transplantation techniques were introduced in the next 10 yr. The introduction ofmicrosurgery into experimental transplantation research was greatlyaided by improvement of auxiliary optical instruments, in particular of operating microscopes, by further development of microsurgical instruments, by availability of various inbred rat strains and by fine atraumatic needle-suture combinations of various shapes and sizes. Thus microsurgery became an auxiliary technique for various disciplines in experimental medicine.
In rats, cardiac transplantation has been performed with models of 'empty' beating hearts that were connected either to neck vessels or the abdominal vessels. This procedure provides immunological and functional results which can be standard-ized and give reproducible results. On the other hand, orthotopic cardiac transplantation, which would be a highly desirable experimental model in rats, has not been successfully introduced as yet, primarily due to difficulties associated with miniaturization of extra-corporal systems suitable for such small animals.
MATERIAL AND METHODS

Technique of Transplantation
Our technique of heart transplantation in the rat is an adaptation of the procedures used previously by other investigators (13) and is performed in 3 stages: a) preparation of the recipient; b) removal of the donor's heart; and c) transplantation of the donor's heart in the recipient. The critical parts of the procedures are performed under an operating microscope using 15-30 x magnification.
Stage 1
The recipient (300-400 g of body weight) is anesthetized with sodium pentobarbital (Nembutale) (40 mg/kg, ip). The skin of the abdominal cavity is opened from the symphysis to the xyphoid process and the wall of the abdomen is then opened along the linea alba. The content ofthe abdomen is moved 541 TOXICOLOGIC PATHOLOGY . The remaining connections between the heart and other organs are cut, the heart is removed from the thoracic cavity, and kept in ice cold saline.
Stage 3
The recipient's abdominal aorta and inferior vena cava are clamped offusing a curved, rubber-covered pediatric hemostat and elliptical incisions are made on the above vessels using Castroviejo curved eye scissors. The end-to-side anastomoses of the aortic stump to the abdominal aorta and ofthe pulmonary artery stump to the inferior vena cava are accomplished by continuous circular stitches (Fig. 2 ). The clamps are then intermittently released, and the anastomoses fully compressed with a "Tefla" pad to facilitate the blood clotting. After slowly and intermittently releasing the clamp, the transplanted heart is gradually perfused through its coronary circulation and commences to beat after the cardioplegic solution is replaced by the perfusing blood.
Postoperative care is essential to maintain good survival. Immediately after surgery the animal is kept on an electrical warming pad and observed until its starts to move. In case of increased bronchial secretion, the mucus is carefully aspirated and a short term mechanical ventilation, if necessary, is applied. Antibiotics are injected: "Penbritin-250" in one single dose 60 mg/animal intramusculary and "Gentocin" for 7 consecutive days 1.5 mg/rat/day subcutaneously.
The entire procedure takes a skillful surgeon trained for this technique less than I hr, while stage 3 takes about 30-40 min; failure to restart the trans- to the left, wrapped in the gauze soaked with warm saline, and the abdominal aorta and the inferior vena cava are separated from each other and from the dorsal wall. The wound is then covered with saline-soaked gauze.
Stage 2
The donor (300-400 g of body weight) is anesthetized as above, heparinized, and bled. The thoracic cavity is opened and the heart is quickly arrested with crushed ice and saline. The right carotid artery is clamped with a small vascular clamp. The aortic arch is cut and a temporary cannula is inserted into the aorta in order to flush the heart with approximately 20 ml ofcardioplegic solution (Plegisol, Abbott's Laboratories). The superior and inferior vena cava are ligated, and another ligature is passed under the pulmonary artery around the pulmonary veins and vena azygous and tied. The aortic arch plant occurs in about 5% of cases. Another 10% of the transplants cease to function within 2 months after the operation, so that the surviving fraction of viable transplants represents more than 80% of the original number ofoperated animals. The recipients with beating transplants are kept in individual cages and their body weight and the heart rate ofthe transplant regularly monitored. This time period depends on the character of the experiment and may last from several days to up to 2 yr.
Hemodynamic Function of the Transplant
As can be seen from the cross-sectional diagram in Fig. 2 , the coronary flowin the transplant is maintained through the ostia of coronary arteries in the aortic stump and through the intact of the coronary vasculature. Consequently, the majority of the coronary blood flow returns via the coronary sinus and the auxiliary openings in the right ventricle and is ejected via the pulmonary artery into the inferior vena cava ofthe recipient. Part ofthe coronary flow in the left ventricle is drained directly via the Thebesian veins into the cavity of the left ventricle and this allows for gradual filling of the left ventricle throughout the cardiac cycle.
The driving force for the coronary flow is the arterial pressure in the abdominal aorta of the recipient which normally oscillates between 80 and 140 mm Hg. The heart rate of the transplant ranges between 220-240 beats/min which is the intrinsic heart rate of the sino-atrial node of denervated rat heart. The pressure inside the left ventricle of the transplant oscillates between 0 at the beginning of the diastole and 80-105 mm Hg at the peak of systole, which is dependent on the pressure maintained in the aortic stump of the recipient. The pressures in the right ventricle are between 22-28 mm Hg depending on the magnitude of coronary flow and the site of the orifice of the anastomosis between the pulmonary artery and inferior vena cava of the recipient, where the pressure is usually 6-8 mm Hg. The left ventricle beats mostly isovolumically with occasional ejections whenever the peak systolic pressure is higher than the pressure in the aortic stump, which depends on the oscillatory pressure in the abdominal aorta. The heart in situ beats at the higher rate (340-360 beats/min) and a phase shift necessarily occurs between the cardiac cycles of the transplant ofthe recipient. Consequently, the peak systolic pressure in the transplant occasionally faces the lower diastolic pressure in the abdominal aorta of the recipient and ejection may occur at this particular moment.
In view of the above, this preparation represents a Langendorf 'non-working' heart which is inside the body and is perfused with the donor's arterial blood. If the operation is properly executed and no thrombosis occurs in the transplant, the transplant maintains its intrinsic rate and can successfully function for an extended period of weeksand months in the abdominal cavity.
Prerequisitesfor Successful Transplantation
The microsurgical prerequisites for successful experimental transplantation require the following: auxiliary optical equipment, microsurgical instruments, inbred rats and particularly fine atraumatic needle/suture combinations. We employ either magnifying glasses with magnification up to 6 times for the less critical parts of the operation and an operating microscope with magnification up to 30fold for the fine suturing. The latter has better resolution but a smaller depth of focus and field of view. Illumination of the area of operation is of critical importance and we use built-in lamps and also additional lamps to throw light to less accessible areas. We employ microsurgical instruments which are commonly used in eye surgery or microvasculature surgery. The same applies for atraumatic needle/suture combinations. As far as selection of a suitable surgical technician for the above procedure, the following prerequisites are essential. The surgeon has to have excellent hand to eye coordination in order to acquire the necessary skills. The success rate of the transplantation depends to a high degree on the accuracy of the procedures with which the animals and the techniques are handled. It has been our experience that those surgeons who do not work extremely precisely from the beginning will eventually have high failure rates. In addition to the above, a great degree of concentration is required for an extended period. The procedure has its frustrations and the surgeon has to show a great degree ofjudgement, patience, and perseverance which are equally important as skills.
RESULTS
In the following section, we describe experiments that had been performed in our own and several other investigators' laboratories which show how this model has been applied to study interventions effectingjointly both the heart in situ and the transplant, or the transplant only. They demonstrate not only the merits but also show the limitations of this model for potential future pharmacologic and toxicologic studies.
Effect of Thyroid Hormone on the Phenotype of the Cardiac Myocytes of the In Situ and Heterotopically Isotransplanted Heart
The euthyroid state in mammals is essential for normal growth ofthe myocardium and maintenance TOXICOLOGIC PATHOLOGY of normal heart weight to body weight ratio and it is also essential for the maintenance of normal hemodynamic function of the cardiovascular system in the whole rat and for normal hemodynamic function of the isolated heart in the heart-lung preparation (2) and Beznak (5) . Hypo-and hyperthyroidism have inhibiting and enhancing effects on the above parameters of the mammalian myocardium.
[For review see Zak (16) .]
It was also shown in the rat that the level of thyroid hormones in the body may directly affect the intrinsic mechanics of cardiac muscle, since contraction and relaxation were slower in isolated papillary muscles from hypothyroid and faster from hyperthyroid ones as compared to those from controls (5) . Initially, it was suggested that the underlying mechanism of action of TH may lie primarily in the excitation-contraction coupling as for instance no differences could be demonstrated in glycerinated cardiac myofibers prepared from fast and slow contracting myocardium (6) . Further studies, however, suggested that myosin molecules may not necessarily be monomers and various isomyosins were isolated from skeletal and later cardiac muscles of one and the same species. These isomyosins appear to have not only different electrophoretic mobility, but were found to exist in different proportions in various skeletal muscles and also in various parts ofthe heart, particularly when comparing the atria and ventricles. They represent an important developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Their expression is tissue specific and is an essential characteristic of cell differentiation. They contribute to the plasticity of muscle fibers (14) and are genetically encoded as at least seven members of a multigene family of sarcomeric myosin heavy chain. [For review see Swynghedauw (IS).} It was later shown that in most mammalian species the ventricular myocardium contains at least 2 types of myosin heavy chains HCalpha and HCbeta (11) which assemble to form the 3 isomyosins (Vh V2, and V3)' The expression of heavy chains is controlled by a variety of means and it changes during individual development of the animal. It is greatly influenced by a number of hormones, in particular by thyroid hormone and also by changes in the hemodynamic load (12, 15) .
The regulation of myosin synthesis by thyroid hormone may be achieved by accumulation of HCalpha mRNA and loss of HCbeta mRNA as shown in hyperthyroid rabbits. In these experiments, 4 hr after administration of T3 to hypothyroid animals the HCbeta mRNA was detected to decline while HCalpha mRNA increases in its abundance. Twenty-four hr after T 3 treatment half of the transcribed message corresponded to HCalpha and by 72 hr after treatment the contribution of HCalpha mRNA to the synthesis of total myosin mRNA rose to 90%. The relative synthesis of HCalpha and HCbeta reflected then the relative abundance of respective mRNA and these changes were much more dramatic than assessment ofelectrophoretically separated VI and V 3 isomyosin. This is because quantitation of mRNA is more sensitive than measurements of protein content (16) .
The above data suggestthat thyroid hormone regulation of cardiac myosin synthesis occurs at the transcriptional rather than the translational level. Thus, most probably thyroid hormone may activate receptors located in the nuclei leading to induction of myosin synthesis and to selective activation of gene transcription which results in modification of relative synthesis of HCalpha mRNA and HCbeta mRNA. In addition to this postulated direct effect of thyroid hormone, we have to consider the initial increase of hemodynamic load and activation of adrenergic nerves ofthe heart which are both known to play a role in mediating the effect of TH upon the myocardium. We reasoned that if we could dissociate the latter 2 mechanisms from the former one and still get the selective activation of relative synthesis of HCalpha and suppression of HCbeta, we could prove the direct effect of thyroid hormone on the myocyte. This could be achieved either in a tissue culture ofmyocytes or in a denervated heterotopically isotransplanted heart that does not support hemodynamic load.
In collaboration with Dr. Zak, we decided to pursue this line of reasoning by experiments in tissue culture (in his laboratory) and in denervated heterotopically isotransplanted hearts (8) that do not support hemodynamic load (in my laboratory). When I studied the role of chronic unloading on myocardial fibre orientation (7) utilizing the model of heterotopically isotransplanted viable rat heart which did not produce external cardiac work, I noticed a considerable alteration of fibre orientation in the ventricular wall leading ultimately to fibre disarray. When we analyzed the spectrum of isomyosins in these hearts, we found a considerable shift of VI to V 3 isomyosins. These rather unexpected findingscould be reproduced in collaboration with Dr. Zak in another strain of inbred rats and under different experimental conditions (9) . We could also show that a complete reversal from almost pure myocardial V 3 to almost pure VI could be achieved by administering T3 to severely hypothyroid host rats containing a heterotopically transplanted heart from severely hypothyroid donors of the same inbred strain (9) . Since the transplant does not support the increased hemodynamic load in-duced by administration of T3, we concluded that the selective synthesis of cardiac isomyosins induced by T3 could not be load-dependent. On the other hand, T 3 could restore the mass ofthe atrophic hypothyroid heart of the recipient to normal and later induce its hypertrophy while it had no such effect upon the transplant. Similar results using this model were also obtained by Klein et al (3, 4) .
The Effect ofSwimming Exercise on the Heart In Situ and Heterotopic Isograft
Recently, Advanti et al (l) investigated the effect of chronic swimming exercise on the rat heart in situ and on the heterotopic isotransplant in the abdominal cavity. They showed that swimming resulted in a moderate hypertrophy of the in situ heart in both operated and unoperated rats as compared to sedentary controls. However, the cardiac transplants showed the expected degree atrophy which was not attenuated by swimming. On the other hand, a restructuring ofisomyosin spectrum was observed in the swimming rats in both the heart in situ and in the tranplants. The usually observed decrease in VI isomyosin in the transplants could be significantly attenuated by swimming and swimming also increased the percentage of VI of isomyosin in the in situ hearts of the operated rats. Similarly, as in our previously described experiments, these authors demonstrated that the additional load on the in situ heart resulted in no increase of cardiac mass in the transplant. This occurred in spite of the selective effect of the swimming exercise upon the isomyosin spectrum in the transplant in which, once again, no attenuation of atrophy could be observed.
Direct Increase ofHemodynamic Load in the Transplant
The above experiments indicate that, in spite of the fact that considerable increase in the hemodynamics of the heart in situ can be achieved by thyroxine which ultimately leads to increased cardiac mass and changes in the isomyosin spectrum, no indirect effects could stimulate the growth of the isotransplant. It was felt that at this stage the only way to stimulate cardiac growth of the transplant, or at least attenuate its atrophy, would be to increase directly the hemodynamic load of the transplant.
In our recent experiments, 2 avenues were approached (l0). One was an attempt to damage the leaflet of the aortic valve of the transplant with the intention to cause aortic insufficiency. This should ultimately lead to an increase in left ventricular end diastolic pressure and left ventricular end diastolic volume, thus, hopefully increasing the systolic wall stress of the left ventricle of the transplant. U nfortunately, this approach proved to be unworkable, at least in our hands so far, and consequently we decided to damage the mechanics of the aortic valve by inserting a short polyethylene stent through the aortic valve and into the left ventricle of the donor heart before the transplantation. Our original intention was to cause partial insufficiency and some degree of stenosis which may eventually lead to increased left ventricular end diastolic pressure and increased peak systolic pressure, thus, increasing exclusively the hemodynamic load ofthe left ventricle of the transplant.
The preliminary experiments indicate that the transplant with inserted polyethylene stent exhibits overload as manifested by an increase of end diastolic and peak systolic pressures in the left ventricles. This procedure also led to a significant attenuation of the process atrophy in the left ventricle.
The mean values of the left ventricular mass after a period of 10-15 days were consequently significantly higher than those in control transplants which were not overloaded. The overloaded transplant as compared to the normal transplant showed an increased end diastolic and peak systolic left ventricular pressures, increased rate pressure product, and significantly larger mass ofthe left ventricle as compared to the respective values in normal transplants. In 3 out of 15 animals in this group, in which both the aortic insufficiency and stenosis were achieved, a high increase in left ventricular end diastolic pressure led to the high increase of peak systolic pressure, resulting in a significantly higher peak in systolic pressures in the left ventricle of the transplant than in the aorta of the recipient. Consequently, in these 3 cases, a hypertrophy of a moderate degree was induced as compared to the left ventricular mass oftheir in situ recipient hearts. This, in our opinion, is the first time that clear proof was obtained demonstrating that the mass of the heart, which is not innervated, does not support hemodynamic load of the whole body, is normal in internal humoral environment, and can be increased by augmented hemodynamic load only as compared to the control heart in situ.
